Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo

Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine

1980 • 4,407 citations

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

1995 • 4,003 citations

The ferritins: molecular properties, iron storage function and cellular regulation

1996 • 2,572 citations

Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice

2001 • 1,418 citations

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1989 • 1,367 citations

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

1997 • 1,304 citations

Oxidative stress and Alzheimer disease

2000 • 1,127 citations

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

1994 • 1,120 citations

Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

1989 • 1,117 citations

Mice Deficient in Cellular Glutathione Peroxidase Show Increased Vulnerability to Malonate, 3-Nitropropionic Acid, and 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine

2000 • 1,112 citations

ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA

1991 • 1,012 citations

Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

1992 • 964 citations

New stereological methods for counting neurons

1993 • 951 citations

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

2001 • 775 citations

Cu(II) Potentiation of Alzheimer Aβ Neurotoxicity

1999 • 748 citations

Parkinson's disease: A disorder due to nigral glutathione deficiency?

1982 • 746 citations

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

1988 • 738 citations

Metals and neuroscience

2000 • 724 citations

Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?

1994 • 701 citations

Experimental models of Parkinson's disease

2001 • 617 citations

Regionally specific loss of neurons in the aging human hippocampus

1993 • 612 citations

Animal models of Parkinson's disease

2002 • 580 citations

Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease

2001 • 533 citations

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

1991 • 516 citations

The regional distribution and cellular localization of iron in the rat brain

1984 • 487 citations

Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity.

1992 • 487 citations

Brain iron and ferritin in Parkinson's and Alzheimer's diseases

1990 • 440 citations

Oxidative damage in neurodegenerative disease

1994 • 428 citations

Behavioral phenotyping of the MPTP mouse model of Parkinson's disease

2001 • 422 citations

Ferritin and the response to oxidative stress

2001 • 410 citations

Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes

2001 • 381 citations

Regional distribution of iron and iron‐regulatory proteins in the brain in aging and Alzheimer's disease

1992 • 367 citations

Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients

1986 • 364 citations

Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

2001 • 360 citations

Brain iron pathways and their relevance to Parkinson's disease

2001 • 356 citations

A Quantitative Analysis of Isoferritins in Select Regions of Aged, Parkinsonian, and Alzheimer's Diseased Brains

1995 • 320 citations

The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism

1999 • 304 citations

The possible role of iron in the etiopathology of parkinson's disease

1993 • 303 citations

Oxygen free radicals and Parkinson's disease

1991 • 293 citations

New insights into the cause of Parkinson's disease

1992 • 272 citations

Overexpression of Wild Type and Mutated Human Ferritin H-chain in HeLa Cells

2000 • 245 citations

Sequestration of iron by Lewy bodies in Parkinson's disease

2000 • 243 citations

Complex I, Iron, and ferritin in Parkinson's disease substantia nigra

1994 • 239 citations

Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain

1993 • 237 citations

Iron and neurodegenerative disorders

2001 • 235 citations

The Role of Iron in Neurodegeneration

1999 • 220 citations

Iron in the basal ganglia in Parkinson's disease

1999 • 216 citations

A Mutation, in the Iron-Responsive Element of H Ferritin mRNA, Causing Autosomal Dominant Iron Overload

2001 • 211 citations

The mosaic of brain glial hyperactivity during normal ageing and its attenuation by food restriction

1999 • 199 citations

Iron and oxygen radicals in brain

1992 • 186 citations

MR evaluation of age-related increase of brain iron in young adult and older normal males

1997 • 182 citations

Isoforms of ferritin have a specific cellular distribution in the brain

1994 • 175 citations

Iron and iron management proteins in neurobiology

2001 • 174 citations

In Vitro Studies of Ferritin Iron Release and Neurotoxicity

1998 • 152 citations

NEUROLOGICAL SYNDROME ASSOCIATED WITH CLIOQUINOL

1971 • 152 citations

11 The toxic effects of desferrioxamine

1989 • 138 citations

Aceruloplasminemia

1998 • 137 citations

Metals and Oxidative Damage in Neurological Disorders

1997 • 126 citations

Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment

1986 • 125 citations

Changes in uptake of vitamin B12 and trace metals in brains of mice treated with clioquinol

2000 • 125 citations

Mitochondria and free radicals in neurodegenerative diseases

1997 • 124 citations

Cellular distribution of ferritin subunits in postnatal rat brain

1998 • 119 citations

Excessive iron accumulation in the brain: A possible potential risk of neurodegeneration in Parkinson's disease

1997 • 100 citations

5' flanking sequences of the rat tyrosine hydroxylase gene target accurate tissue-specific, developmental, and transsynaptic expression in transgenic mice

1992 • 99 citations

MPTP Produces Differential Oxidative Stress and Antioxidative Responses in the Nigrostriatal and Mesolimbic Dopaminergic Pathways

1998 • 93 citations

Subacute myelo‐optico‐neuropathy: Clioquinol intoxication in humans and animals

2000 • 88 citations

The iron-responsive element is the single element responsible for iron-dependent translational regulation of ferritin biosynthesis. Evidence for function as the binding site for a translational repressor.

1988 • 87 citations

Cloning, characterization, expression, and chromosomal localization of a human ferritin heavy-chain gene.

1986 • 83 citations

Role of H and L Subunits in Mouse Ferritin

1996 • 77 citations

The Potential Role of Iron Chelators in the Treatment of Parkinson's Disease and Related Neurological Disorders

1997 • 77 citations

Subacute myelo-optic neuropathy and clioquinol. An epidemiological case-history for diagnosis.

1975 • 76 citations

RELATION BETWEEN SUBACUTE MYELO-OPTIC NEUROPATHY (S.M.O.N.) AND CLIOQUINOL: NATIONWIDE SURVEY

1973 • 74 citations

MPTP-induced parkinsonism as a model for Parkinson's disease

1989 • 69 citations

Release of iron from ferritin by metabolites of benzene and superoxide radical generating agents

2001 • 69 citations

Brain iron: location and function.

1993 • 63 citations

Neurotoxicity of halogenated hydroxyquinolines: clinical analysis of cases reported outside Japan.

1979 • 62 citations

Cellular distribution of ferric iron, ferritin, transferrin and divalent metal transporter 1 (DMT1) in substantia nigra and basal ganglia of normal and beta2-microglobulin deficient mouse brain.

2000 • 58 citations

XAFS spectroscopy of a single neuron from a patient with Parkinson's disease

2001 • 51 citations

Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3-6-tetrahydropyridine (MPTP)-treated rat

1993 • 37 citations

The same chemicals induce different neurotoxicity when administered in high doses for short term or low doses for long term to rats and dogs

1992 • 34 citations

Toxic effects of high-dose deferoxamine treatment in patients with iron overload: an electrophysiological study of cerebral and visual function.

1991 • 32 citations

Iron deficiency alters H- and L-ferritin expression in rat brain.

2000 • 32 citations

Topographical localization of iron in brains of the aged fat-tailed dwarf lemur(Cheirogaleus medius) and gray lesser mouse lemur(Microcebus murinus)

1998 • 28 citations

Mitochondria and Free Radicals in Neurodegenerative Diseases

1998 • 26 citations

Free Radicals and MPTP-Induced Selective Destruction of Substantia Nigra Cornpacta Neurons

1997 • 26 citations

The Role of Iron in Parkinson Disease and 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Toxicity

1999 • 24 citations

Clioquinol neurotoxicity: an overview.

1984 • 23 citations

Elevation of neuronal MAO-B activity in a transgenic mouse model does not increase sensitivity to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

1994 • 22 citations

‘…and C is for Clioquinol’ – the AβCs of Alzheimer's disease

2002 • 20 citations

Do Alterations in Glutathione and Iron Levels Contribute to Pathology Associated with Parkinson's Disease?

2001 • 17 citations

A Welcome to IUBMB Life

1999 • 12 citations

Mass spectrometry of 5-chloro-7-iodo-8-quino-linol metal chelates

1974 • 10 citations

[Subacute myelo-optico-neuropathy].

1980 • 4 citations